We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-4.68%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$17.7B
AUM Growth
-$815M
Cap. Flow
+$169M
Cap. Flow %
0.95%
Top 10 Hldgs %
18.06%
Holding
3,210
New
168
Increased
1,509
Reduced
1,241
Closed
160

Sector Composition

Rank Sector Weight
1 Technology 8.86%
2 Financials 4.76%
3 Consumer Discretionary 4.5%
4 Healthcare 4.18%
5 Consumer Staples 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOTZ
3026
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$6K ﹤0.01%
18,701
CNSP icon
3027
CNS Pharmaceuticals
CNSP
$7.32M
0
BINI
3028
DELISTED
Bollinger Innovations
BINI
0
VERO
3029
DELISTED
Venus Concept
VERO
$5K ﹤0.01%
68
DCOY
3030
Decoy Therapeutics
DCOY
$1.92M
$4K ﹤0.01%
1
TLPH icon
3031
Talphera
TLPH
$72.7M
$4K ﹤0.01%
909
-350
-28% -$1.83K
GMBL
3032
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
$4K ﹤0.01%
1
ASAP
3033
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$4K ﹤0.01%
1,445
AVCT
3034
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$4K ﹤0.01%
+1,170
New +$4.01K
AEI icon
3035
Alset
AEI
$43.6M
$3K ﹤0.01%
+550
New +$3.11K
TALKW
3036
DELISTED
Talkspace Inc Warrant
TALKW
$3K ﹤0.01%
10,550
NXTP
3037
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$3K ﹤0.01%
750
VGFC
3038
DELISTED
The Very Good Food Company
VGFC
$3K ﹤0.01%
+21,478
New +$4.09K
VTGN icon
3039
VistaGen Therapeutics
VTGN
$11.6M
$2K ﹤0.01%
+351
New +$3.48K
TTOO
3040
DELISTED
T2 Biosystems, Inc
TTOO
$2K ﹤0.01%
4
HEXO
3041
DELISTED
HEXO Corp. Common Shares
HEXO
$2K ﹤0.01%
988
-59
-6% -$168
ACNT icon
3042
Ascent Industries
ACNT
$133M
-59,893
Closed -$842K
ADT icon
3043
ADT
ADT
$5.34B
-10,739
Closed -$66K
ALG icon
3044
Alamo Group
ALG
$2.01B
-6,379
Closed -$743K
ALGT icon
3045
Allegiant Air
ALGT
$2.31B
-2,723
Closed -$308K
AMR icon
3046
Alpha Metallurgical Resources
AMR
$2.02B
-2,062
Closed -$266K
AMSC icon
3047
American Superconductor
AMSC
$1.56B
-81,666
Closed -$423K
ARW icon
3048
Arrow Electronics
ARW
$10.7B
-3,364
Closed -$377K
ASB icon
3049
Associated Banc-Corp
ASB
$6.07B
-15,321
Closed -$280K
ATEN icon
3050
A10 Networks
ATEN
$2B
-64,691
Closed -$930K

Similar funds

Cambridge Investment Research Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Cambridge Investment Research Advisors held 3,210 positions worth $17.7B, down 4.4% from $18.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q3 2022 filing shows 168 new, 1,509 increased, 1,241 reduced and 160 closed positions. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M. The largest sale was iShares S&P Small-Cap 600 Value ETF, an estimated $46M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q3 2022 buy was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M.
  • Cambridge Investment Research Advisors added most to First Trust Enhanced Short Maturity ETF in Q3 2022, an estimated $41.2M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2022 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $46M.
  • Cambridge Investment Research Advisors fully exited Invesco DB Energy Fund in Q3 2022, selling an estimated $5.88M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $17.7B portfolio in Q3 2022.
  • Cambridge Investment Research Advisors opened 168 new positions and closed 160 in Q3 2022.
  • Cambridge Investment Research Advisors's portfolio value fell 4.4% quarter-over-quarter to $17.7B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.